Biomarkers and cytokines of bone turnover: extensive evaluation in a cohort of patients with ankylosing spondylitis
Open Access
- 2 October 2012
- journal article
- Published by Springer Science and Business Media LLC in BMC Musculoskeletal Disorders
- Vol. 13 (1), 191
- https://doi.org/10.1186/1471-2474-13-191
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Osteoporosis: A Paradox in Ankylosing SpondylitisCurrent Osteoporosis Reports, 2011
- Soluble receptor activator of nuclear factor-κB ligand (RANKL) and osteoprotegerin in ankylosing spondylitis: OPG is associated with poor physical mobility and reflects systemic inflammationClinical Rheumatology, 2010
- Osteoporosis in Ankylosing SpondylitisCurrent Rheumatology Reports, 2010
- Evidence that Dkk‐1 is dysfunctional in ankylosing spondylitisArthritis & Rheumatism, 2009
- Receptor activator of nuclear factor kappa B ligand-mediated osteoclastogenesis is elevated in ankylosing spondylitis.2009
- Bone Formation Versus Bone Resorption in Ankylosing SpondylitisAdvances in experimental medicine and biology, 2009
- The role of Wnt proteins in arthritisNature Clinical Practice Rheumatology, 2008
- Joint remodelling in inflammatory diseaseAnnals Of The Rheumatic Diseases, 2007
- Evaluation of bone mineral density, hormones, biochemical markers of bone metabolism, and osteoprotegerin serum levels in patients with ankylosing spondylitis.2004
- Ankylosing spondylitis, psoriatic arthritis, and reactive arthritis show increased bone resorption, but differ with regard to bone formation.2002